• Leadership
    • Management
    • Board
    • Scientific Advisory
  • Technology
  • Pipeline
    • Immuno-oncology
    • GI related disorders
    • MDRO
  • News & Events
    • Press Releases
    • In The Media
    • Events
  • Careers

In The Media

Cancer treatment not working? Gut bacteria could be cure

Aug 10, 2022
Read on 'The Jerusalem Post'

Positive pre-clinical results for Biomica, Evogene’s subsidiary, in its Immuno-Oncology Program

Sep 09, 2020
Read on TheMarker (Hebrew)

Biomica has been recognized by IVC Research Center and Grove Ventures, as a Next-Gen Deep Tech startup in the Israeli healthcare ecosystem, together with other innovative startups

Feb 25, 2020
Read on IVC Annual Israeli Tech Review

Biomica and Weizmann Institute to develop a selective drug for resistant bacteria

Oct 23, 2019
Read on Sponser (Hebrew)

Biomica will develop a product based on revelations from Nobel Prize Laureate Prof. Ada Yonath

Oct 23, 2019
Read on Globes (Hebrew)

Biomica will partner with the Weizmann Institute to develop a selective drug for resistant bacteria

Oct 23, 2019
Read on The Marker (Hebrew)

Biomica has begun preclinical trials of bacterial-based drugs to treat cancer

Apr 16, 2019
Read on The Marker (Hebrew)

Dr. Elran Haber, CEO of Biomica speaking at ILTV Studio about the Israeli Biomedical company that has just revealed what could be the answer to antibiotic-resistance.

May 03, 2018
Watch on YouTube

Evogene returns with a startup in the human microbiome

Apr 30, 2018
Read on Globes (Hebrew)

An Israeli company is developing a a microbiome therapy that can help treat diseases. Is this the next big medical innovation?

Apr 25, 2018
Watch on DailyMotion

13 Gad Feinstein st. Park Rehovot, Israel

Tel: 972-8-9311900 | Fax: 972-8-946672

Info@biomicamed.com

Contact Us

    I want to join the Biomica newsletter

    Copyright © 2023 Biomica. All Rights Reserved

    Designed and built by Studio Praktik